To Evaluate the Efficacy and Safety of Toripalimab Combined With Chemotherapy (Epirubicin + Cyclophosphamide → Nab-paclitaxel + Carboplatin) in the Neoadjuvant Treatment of Triple-negative Breast Cancer After High-intensity Focused Ultrasound (HIFU) Induction
Latest Information Update: 12 Aug 2022
At a glance
- Drugs Carboplatin (Primary) ; Cyclophosphamide (Primary) ; Epirubicin (Primary) ; Paclitaxel (Primary) ; Toripalimab (Primary)
- Indications Early breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 12 Aug 2022 New trial record